Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Everolimus | Everolimus .25 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-069 |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-070 |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-071 |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-090 |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-091 |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-092 |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-112 |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-773 |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-774 |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-775 |
| Everolimus | Everolimus .25 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-003 |
| Everolimus | Everolimus .5 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-015 |
| Everolimus | Everolimus .75 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-016 |
| Everolimus | Everolimus 1 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-017 |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-254 |
| Everolimus | Everolimus 5 mg/1 | TabletOral | NorthStar RxLLC | 72603-255 |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-256 |
| Everolimus | Everolimus 10 mg/1 | TabletOral | NorthStar RxLLC | 72603-257 |
| everolimus | Everolimus 2.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-030 |
| everolimus | Everolimus 5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-031 |
| everolimus | Everolimus 7.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-032 |
| everolimus | Everolimus 10 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-033 |
| Fotivdativozanib | Tivozanib hydrochloride .89 mg/1 | CapsuleOral | AVEO Pharmaceuticals, Inc. | 45629-089 |
| Fotivdativozanib | Tivozanib hydrochloride 1.34 mg/1 | CapsuleOral | AVEO Pharmaceuticals, Inc. | 45629-134 |
| Fyarrosirolimus | Sirolimus 5 mg/mL | Injection, Powder, Lyophilized, For suspensionIntravenous | Aadi Bioscience, Inc. | 80803-153 |